Li Zhou

4.3k citations
158 papers · 3.0k indexed · h-index 32
Topics
Cancer-related Molecular Pathways (11 papers)Ubiquitin and proteasome pathways (10 papers)Cancer Immunotherapy and Biomarkers (10 papers)
Journals
Genes & DevelopmentSHILAP Revista de lepidopterologíaBlood

In The Last Decade

Li Zhou

146 papers receiving 3.0k citations

Peers

Li Zhou
Comparison fields: 5 of 165
  • Molecular Biology 1.6k
  • Cancer Research 620
  • Oncology 497
  • Pulmonary and Respiratory Medicine 315
  • Immunology 297
Replace Jiali Li with:
Jiali Li China
Qian Sun China
Jian Zhang China
Xiaodong Li China
Li Zou China
Li Xu China
Xinyi Wang China
Rong Fan China
Sen Li China
Li Zhou relative to Jiali Li China Jiali Li's profile →
Citations per field
00.5×1.5×
Jiali Li · 1×
Citations per year

Countries citing papers authored by Li Zhou

Since Specialization
Citations

This map shows the geographic impact of Li Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhou more than expected).

Fields of papers citing papers by Li Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhou. The network helps show where Li Zhou may publish in the future.

Co-authorship network of co-authors of Li Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Li Zhou. A scholar is included among the top collaborators of Li Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Zhou. Li Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 2
5 2
6 19
7 8
8 10
9 7
10 5
11 2
12 147
13 145
14 3
15 0
16
CYP2E1 gene rs6413420 polymorphism was first found in the Bouyei ethnic group of China.
2
17 1
18
THE LINKAGE STRUCTURE AND PHYLOGENY OF DMRT GENE FAMILY IN THE TELEOST FISH
1
19
The influence of psychological intervention with leukemia sufferers' psychological status and chemotherapy compliance
2
20 4

About Li Zhou

Li Zhou is a scholar working on Cancer Research, Oncology and Pharmacology, having authored 158 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Cancer Research (620 citations), Molecular Biology (1.6k citations) and Oncology (497 citations). Li Zhou has collaborated with scholars based in China, United States and Tanzania. Frequent co-authors include Feng Gao, Xinfang Yu, Wenbin Liu, Haidan Liu, Wei Li, Wěi Li, Yating Peng, Tianzhu Qiu, Wei Zhu and Tongshan Wang. Their work appears in journals such as Genes & Development, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026